Preclinical Characterization of ADCT-241, an Exatecan-Based Antibody–Drug Conjugate against PSMA for the Treatment of Metastatic Castration-Resistant Prostate Cancer
Authors:
- Asma JabeenAJAsma Jabeen
- Ben LeatherdaleBLBen Leatherdale
- Rebecca MartinRMRebecca Martin
- Valenti GomezVGValenti Gomez
- Danilo CucchiDCDanilo Cucchi
- Banusha RajeenthiraBRBanusha Rajeenthira
- Hafsah OmarHOHafsah Omar
- Alison FaidAFAlison Faid
- Pedro L. AlvesPAPedro L. Alves
- Kristina ZaitsevaKZKristina Zaitseva
- Nicolas VeillardNVNicolas Veillard
- Narinder JanghraNJNarinder Janghra
Open Access
- 28 October 2026
- journal article
- Published by American Association for Cancer Research (AACR) in Molecular Cancer Therapeutics
- p. OF1-OF13